QT
OPTN

Quantamental Technologies’s OptiNose OPTN Stock Holding History

Quantamental Technologies’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-113
Closed -$12K – 1061
2019
Q3 		$12K Buy
113
+31
+38% +$3.09K ﹤0.01% 1293
2019
Q2 		$9K Buy
+82
New +$10.8K ﹤0.01% 1261

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Quantamental Technologies's OPTN Position: Q4 2019 in Review

Quantamental Technologies sold out of OptiNose (OPTN) in Q4 2019, closing a stake of 113 shares — an estimated $12K sold.

Quantamental Technologies first reported a position in OPTN in Q2 2019 and held it in 2 quarters. The position peaked at $12K in Q3 2019. 91 funds tracked by Wall St. Rank hold OPTN as of Q4 2019.

  • Quantamental Technologies reported no remaining OptiNose position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 113 OptiNose shares in Q4 2019, an estimated $12K.
  • Quantamental Technologies first reported a position in OptiNose in Q2 2019 and held it in 2 quarters.
  • Quantamental Technologies's OptiNose position peaked at $12K in Q3 2019.
  • 91 funds tracked by Wall St. Rank held OptiNose as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.